Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Jefferson Research
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
SGS Life Science Services Selects Oracle Corporation's Oracle Health Sciences LabPas to Accelerate Phase I Clinical Trial
SGS Life Science Services announced that it has selected Oracle Health Sciences LabPas to help accelerate subject recruitment, data capture and analysis, and improve workflows in Phase I trials. The organization will use Oracle Health Sciences LabPas delivered via the scalable and secure Oracle Health Sciences Cloud to automate Phase I clinical trial processes and to better integrate early-phase study data with its clinical data management system in order to expedite studies and improve insight. The project will be set up in SGS' Antwerp, Belgium, clinical unit.
Latest Key Developments in Software
- Tyler Technologies Inc Narrows FY 2013 Revenue Guidance To A Range In Line With Analysts' Estimates; Lowers FY 2013 EPS Guidance-Conference Call
- SSBV Rovsing A/S Updates on FY 2012/2013 Financial Guidance
- Halogen Software Inc Completes Initial Public Offering
- ReadSoft AB Completes Acquisition of Systems Development Svenska AB
- Share this
- Link this
- Digg this
Follow Reuters